| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e103faa606dfcb753f8dd9e8e5b220e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74fc4583d847e0c4cceb7ce31194b3fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f26a9731c6f63c8c284c9c9a6de3719
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba99009f983999a0d97c418a0c4fab72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f75cc61295b6c8882ca116d5fb634dca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b04f067358421e8f3cf5f6d8e5313e07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16dd53a9b40e99e39f904ef022a7c51c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42 |
| filingDate |
2006-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80d1d6d58e12fbb56ef4389c05004822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb67d453f6b12acd83415b1f50bd4b7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cc11e771394054772ed7ecfadf4e1a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40e3f6389ffdd6f779c6befd1db34115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0451abd54475a91ac66d7af64e601b21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eff056990b6c66df3fb9897b8bc27cda |
| publicationDate |
2009-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007019448-A3 |
| titleOfInvention |
Nitric oxide enhancing angiotensin ii antagonist compounds, compositions and methods of use |
| abstract |
The invention describes compositions and kits comprising at least one nitric oxide enhancing angiotensin II antagonist compound, or pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitric oxide enhancing angiotensin II antagonist compound, and, optionally, at least one nitric oxide enhancing compound and/or at least one therapeutic agent. The invention also provides methods for (a) treating cardiovascular diseases; (b) treating renovascular diseases; (c) treating diabetes; (d) treating diseases resulting from oxidative stress; (e) treating endothelial dysfunctions; (f) treating diseases caused by endothelial dysfunctions; (g) treating cirrhosis; (h) treating pre-eclampsia; (j) treating osteoporosis; (k) treating nephropathy; (1) treating peripheral vascular diseases; (m) treating portal hypertension (o) treating central nervous system disorders; (p) treating metabolic syndrome; and (q) treating hyperlipidemia. The nitric oxide enhancing angiotensin II antagonist compounds comprise at least one nitric oxide enhancing group linked to the angiotensin II antagonist compound through one or more sites such as carbon, oxygen and/or nitrogen via a bond or moiety that cannot be hydrolyzed. |
| priorityDate |
2005-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |